Dec 6, 2017
HEALTH NEWS DIGEST
“With a smartphone and an app, qualified health care professionals can now diagnose fetal alcohol spectrum disorders (FASD) in their office. FDNA, Inc., a Boston-based biotechnology company, on training a system they developed to recognize the alcohol-related disorder. The app, which can diagnose 300 of the more common genetic disorders is called Face2Gene and uses facial analysis technology.”
The article discusses a groundbreaking smartphone app, Face2Gene, developed to recognize Fetal Alcohol Spectrum Disorders (FASD) with remarkable precision. Using advanced facial analysis technology and artificial intelligence, the Face2Gene app can identify subtle facial characteristics associated with FASD that are often missed by standard diagnostic methods. This innovative decision support tool offers a quick, non-invasive, and highly accessible way for healthcare professionals to screen for FASD, potentially leading to earlier intervention and better outcomes for affected individuals. The Face2Gene app represents a significant advancement in the use of AI in medical diagnostics, providing a crucial resource in the fight against alcohol-related birth defects.
